Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cytek Biosciences Inc
(NQ:
CTKB
)
6.305
-0.075 (-1.18%)
Streaming Delayed Price
Updated: 3:31 PM EDT, May 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cytek Biosciences Inc
< Previous
1
2
Next >
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe
April 30, 2024
Company to Conduct Educational Workshops and Tutorials at CYTO and AAI’s IMMUNOLOGY2024
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024
April 29, 2024
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Names William McCombe Chief Financial Officer
March 19, 2024
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
March 07, 2024
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
February 28, 2024
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Participate in Upcoming Investor Conferences
February 07, 2024
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 07, 2024
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
January 17, 2024
Cytek’s Cutting-Edge Spectral Flow Cytometry Technology, Specialized Staff, Tools and Solutions Set New Benchmarks for Cell Analysis
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
January 08, 2024
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference
December 28, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry
December 21, 2023
New System Saves Time and Resources, Improves Efficiency and Accuracy
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference
November 14, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year’
November 08, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences Reports Third Quarter 2023 Financial Results
November 07, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023
October 19, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Achieves ISO 13485 Certification at Headquarters
September 27, 2023
Certification Validates Company’s Commitment to Quality in all Areas, Helping to Advance Roadmap for Translational and Clinical Markets in the United States
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 20, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe
September 20, 2023
Company to Lead Symposiums at ICCS and ESCCA
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
September 14, 2023
The Cytek Reveal Roadshow Will Provide Insights to Accelerate Discoveries – from Basic Science to Highly Complex Assays
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to participate in the Morgan Stanley 21st Annual Global Healthcare Conference
September 06, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services
August 28, 2023
Sales Organization Enhanced, Platform Organization Created
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Participate in the UBS MedTech, Tools and Genomics Summit
August 10, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences Reports Second Quarter 2023 Financial Results
August 08, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023
July 20, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Participate in the 44th Annual Goldman Sachs Healthcare Conference
May 31, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences Announces $50 Million Stock Repurchase Program
May 19, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward
May 16, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences Reports First Quarter 2023 Financial Results
May 09, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023
April 20, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Introduces New 20-Color AML Panel
March 07, 2023
Optimized for Cytek Cell Analysis Systems; Single-Tube Panel Accelerates Acute Myeloid Leukemia Research and MRD Detection
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.